Ikena Oncology Inc (NASDAQ: IKNA) is garnering attention with its oncology-focused pipeline, and the company's recent developments have raised optimism in the medical community.
Yesterday, 10:28 AM
Walgreens Boots Alliance Inc (NASDAQ: WBA) is in hot water as it grapples with a proposed class action lawsuit in Florida federal court alleging that the pharmacy retailer mislabeled eyedrops designed to treat pink eye (conjunctivitis), misleading consumers into believing the product was safe and effect
Yesterday, 10:18 AM
Bristol Myers Squibb & Co (NYSE: BMY) announced interim data from Phase 3 CheckMate -77T trial evaluating the perioperative regimen of neoadjuvant (before surgery) Opdivo (nivolumab) with chemotherapy followed by surgery and
Yesterday, 7:54 AM
California Attorney General Rob Bonta has taken legal action against two anti-abortion organizations, Heartbeat International (HBI) and RealOptions Obria, for making unsupported claims about reversing the effects of the
Yesterday, 7:49 AM
Pharmaceutical companies are harnessing artificial intelligence (AI) to speed up the traditionally arduous process of clinical trials, potentially saving both time and significant sums of money. These human studies, crucial to drug development, can take years and accrue costs in the billions.
September 21, 4:06 PM
Thursday, CymaBay Therapeutics Inc (NASDAQ: CBAY) initiated the AFFIRM Phase 3b/4 confirmatory study to evaluate the effect of seladelpar on clinical outcomes in patients with compensated cirrhosis due to